Incyte is a global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of novel medicines.
We are committed to the relentless pursuit of science that can improve the lives of patients.
Our unique expertise in medicinal chemistry and biology has enabled us to create a diversified portfolio of marketed products and clinical candidates, the majority of which were discovered by Incyte scientists. We are advancing a growing pipeline of medicines across Oncology and Inflammation & AutoImmunity.
Headquartered in Wilmington, Delaware, Incyte has more than 1,700 employees and operations in North America, Europe and Asia.
We are proud to have been recently recognized by Forbes as one of the World’s Most Innovative Companies. Additionally, Incyte has consecutively been named a Top Employer by Science Magazine, placing #2 on the 2020 list.
For more information about Incyte, please visit our corporate website at www.incyte.com and follow us on Twitter: www.twitter.com/incyte. See our Community Guidelines: http://bit.ly/2sV0H5W.
Oncology, Immuno-oncology, Targeted Therapy, Immunology, and Inflammation
Biopharmaceutical Company | Solutions for Unmet Medical Needs | Incyte.com
Entity | Type | Tweets | Articles | |
---|---|---|---|---|
Zymeworks Inc. biotech, deeptech, Biotechnology Research | Other 14 Feb 2022 | | ||
Pharmaceutical Commerce Magazine Pharmaceutical Manufacturing | Other 7 Dec 2022 | | ||
Josep Carreras Leukaemia Research Institute biotech, deeptech, Research Services | Other 30 Nov 2022 | | ||
Viatris Pharmaceutical Manufacturing | Other 7 Feb 2022 | | ||
Licensing Executives Society (U.S.A. and Canada), Inc. edtech, legaltech, Non-profit Organizations | Other 13 Nov 2017 | | ||
NYU Langone Health Hospitals and Health Care | Other 22 Sep 2021 | | ||
Takeda Oncology Pharmaceutical Manufacturing | Other 19 Mar 2019 | | ||
Genentech Biotechnology Research | Other 31 Mar 2021 | |